Target intelligence / Profile preview

Matrix metallopeptidase 23A (MMP23A)

Target: MMP23A
Molecular classification: Pseudogene (Human), Metalloprotease, Enzyme (other species)

Overview

Matrix metallopeptidase 23A (MMP23A) is the partially duplicated, centromeric pseudogene of MMP23B in humans. It is part of the matrix metalloproteinase family, enzymes involved in extracellular matrix degradation, but the MMP23A locus does not encode a functional protein in humans. In other mammals, related active homologs have been described within the broader MMP family, which regulate diverse physiological processes including tissue remodeling, cell migration, and responses to injury or inflammation. Human MMP23A is not considered a receptor, enzyme, or therapeutic target as it lacks protein-coding function.

Other names: MIFRMIFR-1MMP21

Beyond the preview

Go deeper on Matrix metallopeptidase 23A (MMP23A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrix metallopeptidase 23A (MMP23A).

Explore the full profile